APA (7th ed.) Citation

L, B., & X, D. (2026). Targeting atherosclerotic inflammation: Advances in NLRP3 inflammasome inhibitors beyond LDL-C. Acta pharmaceutica (Zagreb, Croatia), 76(2), 1. https://doi.org/10.2478/acph-2026-0019

Chicago Style (17th ed.) Citation

L, Bao, and Dai X. "Targeting Atherosclerotic Inflammation: Advances in NLRP3 Inflammasome Inhibitors Beyond LDL-C." Acta Pharmaceutica (Zagreb, Croatia) 76, no. 2 (2026): 1. https://doi.org/10.2478/acph-2026-0019.

MLA (9th ed.) Citation

L, Bao, and Dai X. "Targeting Atherosclerotic Inflammation: Advances in NLRP3 Inflammasome Inhibitors Beyond LDL-C." Acta Pharmaceutica (Zagreb, Croatia), vol. 76, no. 2, 2026, p. 1, https://doi.org/10.2478/acph-2026-0019.